Third Time’s a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.
As an investigational diabetes drug implant that promises better adherence faces FDA review for a third time, safety concerns ranging...
As an investigational diabetes drug implant that promises better adherence faces FDA review for a third time, safety concerns ranging...
Dr. Nadiya Sunderji President and CEO, Waypoint. What an incredible year it’s been since I became President and CEO of...
Abby Madore covers a lot of ground each day at work. A staffer at a community health center in Carson...
Rick Jaenisch went through treatment six times before his hepatitis C was cured in 2017. Each time his doctors recommended...
A UCLA study finds that lower NFL jersey numbers tend to be associated with the idea that a player's body...
Published on March 9, 2023The tax filing deadline is April 18, 2023. If anyone in your household had a Marketplace...
Glioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0 An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration...
The FDA approved momelotinib (Ojjaara) as the first therapy specifically for intermediate- and high-risk myelofibrosis with anemia, GSK announced. Almost...
A British nurse was found guilty on Friday in the deaths of seven newborns and the attempted murders of six...
In a recent study published in Scientific Reports, researchers investigated whether a cocktail of bacteriophages coding for the depolymerase polysaccharide...
Amy Maxmen Nurses, researchers, and workplace safety officers worry new guidelines from the Centers for Disease Control and Prevention might...